Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uroxatrol for urinary morbidity after prostate brachytherapy
NCT00201630Phase 3Unknown
- Sponsor
- New York Prostate Institute
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alfuzosin in lower urinary tract symptoms (LUTS), sponsored by New York Prostate Institute. Status: unknown.
02
Drugs
alfuzosin
03
Conditions
lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT00201630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201630.